Estimation of cigarette smoking-attributable morbidity in the United States

JAMA Internal Medicine

Volumn 174, Issue 12, 2014, Pages 1922-1928

  Rostron, Brian L ^a   Chang, Cindy M ^a   Pechacek, Terry F ^b  

^a CENTER FOR TOBACCO PRODUCTS   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTRIBUTABLE RISK; BLADDER CANCER; CEREBROVASCULAR ACCIDENT; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLORECTAL CANCER; DIABETES MELLITUS; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; HEART INFARCTION; HUMAN; KIDNEY CANCER; LARYNX CANCER; LIP CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MOUTH CANCER; PHARYNX CANCER; PREVALENCE; RISK ASSESSMENT; SELF REPORT; SEX DIFFERENCE; SMOKING; SPIROMETRY; STOMACH CANCER; TONGUE CANCER; UNITED STATES; UTERINE CERVIX CANCER; AGED; COST OF ILLNESS; HEALTH SURVEY; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ADULT; AGED; COST OF ILLNESS; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; MORBIDITY; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; SMOKING; SPIROMETRY; UNITED STATES;

EID: 84919471176     PISSN: 21686106     EISSN: 21686114     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.5219     Document Type: Article

References (32)

1. US Department of Health and Human Services. The Health Consequences of Smoking: a Report of the Surgeon General. Washington, DC: National Library of Medicine; 2004.
2. Centers for Disease Control and Prevention. Smoking-attributable mortality, years of potential life lost, and economic costs: United States, 1995-1999. MMWR Morb Mortal Wkly Rep. 2002;51(14):300-303.
3. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 [correction appears in Lancet. 2013;381(9867):628]. Lancet. 2012;380(9859):2224-2260.
4. Centers for Disease Control and Prevention. Annual smoking-attributable mortality, years of potential life lost, and productivity losses: United States, 1997-2001. MMWR Morb Mortal Wkly Rep. 2005;54(25):625-628.
5. Centers for Disease Control and Prevention. Smoking-attributable mortality, morbidity, and economic costs (SAMMEC). http://apps.nccd.cdc.gov/sammec/. Accessed October 12, 2012.
6. US Department of Health and Human Services. How Tobacco Smoke Causes Disease: the Biology and Behavioral Basis for Smoking-Attributable Disease, 2010: a Report of the Surgeon General. Washington, DC: US Dept of Health and Human Services; 2010.
7. Centers for Disease Control and Prevention. Cigarette smoking-attributable morbidity: United States, 2000. MMWR Morb Mortal Wkly Rep. 2003;52(35):842-844.
8. US Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress: A Report of the Surgeon General. Washington, DC: National Library of Medicine; 2014.
9. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2000;160(11):1683-1689.
10. Bednarek M, Maciejewski J, Wozniak M, Kuca P, Zielinski J. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax. 2008;63(5):402-407.
11. Lindberg A, Bjerg A, Rönmark E, Larsson LG, Lundbäck B. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking report from the Obstructive Lung Disease in Northern Sweden Studies [correction appears in Respir Med. 2007;101(12):2569]. Respir Med. 2006;100(2):264-272.
12. Willi C, Bodenmann P, GhaliWA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2007;298(22):2654-2664.
13. Secretan B, Straif K, Baan R, et al; WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol. 2009;10(11):1033-1034.
14. Census Bureau. Population estimates: vintage 2009. http://www.census.gov/popest/data/historical/2000s/vintage-2009/. Accessed October 29, 2013.
15. National Center for Health Statistics. National Health Interview Survey website. http://www.cdc.gov/nchs/nhis.htm. Accessed June 25, 2014.
16. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702-706.
17. Rostron B. Smoking-attributable mortality by cause in the United States: revising the CDC's data and estimates. Nicotine Tob Res. 2013;15(1):238-246.
18. R: a language and environment for statistical computing [computer program]. Version 2.15.2. Vienna, Austria: R Development Core Team; 2012.
19. Survey: analysis of complex survey samples. Version 3.29. Seattle,WA: Thomas Lumley; 2012.
20. National Center for Health Statistics. National Health and Nutrition Examination Survey website. http://www.cdc.gov/nchs/nhanes.htm. Accessed October 1, 2012.
21. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256-1276.
22. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347-365.
23. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179-187.
24. Rabe KF, Hurd S, Anzueto A, et al; Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532-555.
25. Nathell L, NathellM, Malmberg P, Larsson K. COPD diagnosis related to different guidelines and spirometry techniques. Respir Res. 2007;8:89.
26. Viegi G, Pedreschi M, Pistelli F, et al. Prevalence of airways obstruction in a general population: European Respiratory Society vs American Thoracic Society definition. Chest. 2000;117(5)(suppl 2):339S-345S.
27. Celli BR, Halbert RJ, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. Eur Respir J. 2003;22(2):268-273.
28. Kerstjens HA. The GOLD classification has not advanced understanding of COPD. Am J Respir Crit Care Med. 2004;170(3):212-214.
29. Quanjer PH, Enright PL,MillerMR, et al; Pulmonaria Group. Open letter: the need to change themethod for definingmild airway obstruction. Prim Care Respir J. 2010;19(3):288-291.
30. Qaseem A, Wilt TJ, Weinberger SE, et al; American College of Physicians; American College of Chest Physicians; American Thoracic Society; European Respiratory Society. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155(3):179-191.
31. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System. http://www.cdc.gov/brfss/. Accessed November 15, 2012.
32. Rostron B. Mortality risks associated with environmental tobacco smoke exposure in the United States. Nicotine Tob Res. 2013;15(10):1722-1728.